Randomized periodontal trials can establish internally valid effects under specified clinical and organizational conditions, yet those effects may not translate directly to populations treated within different disease, maintenance, financing, and service-delivery environments. Conventional discussions of external validity often underrepresent the dependence of long-term periodontal outcomes on continued supportive care and access to tooth-preserving treatment. This non-empirical methodological analysis integrates contemporary transportability methods with evidence on periodontal disease heterogeneity, social patterning, treatment pathways, supportive periodontal care, and health-system access. It separates statistical transport of trial estimates from the broader clinical question of whether the intervention package, maintenance environment, outcome definition, and treatment alternatives observed in a trial remain achievable in a target system. Transportability in periodontology cannot be judged from demographic similarity alone. Three linked dimensions require explicit evaluation: the baseline periodontal state and progression profile of the target population; the capacity to deliver and sustain the maintenance conditions on which long-term outcomes depend; and access to timely tooth-preserving treatment before disease progression closes therapeutic options. Differences in these dimensions can alter absolute benefit, realized treatment exposure, outcome interpretation, and the relevance of trial comparators even when trial efficacy estimates are internally credible. Periodontal trial transportability is best treated as a conditional inference about an intervention embedded within a care pathway rather than as a property of the trial alone. Explicit source–target characterization is required before evidence generated in one health system is interpreted as directly applicable to another.